Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity in patients with idiopathic pulmonary fibrosis (IPF)

Authors :: Noble, P. W.
Albera, C.
Bradford, W. Z.
Costabel, Ulrich
Glaspole, I.
Glassberg, M. K.
Lancaster, L.
Lederer, D. J.
Lin, Z.
Pereira, C. A.
Swigris, J. J.
Valeyre, D.
Nathan, S. D.
Publication Year :: 2015

Tools